In conclusion, our study provides strong support for a role for COX-1 in HGSOC and continued development of COX-1 as a viable molecular target for diagnostic, chemopreventive, and therapeutic purposes in HGSOC tumors, the most common and aggressive type of ovarian cancer. The gene discussed is PTGS1; the disease is ovarian carcinoma.